Intermittent Schedules of the Oral RAF/MEK Inhibitor CH5126766/VS-6766 in Patients With RAS/RAF-Mutant Solid Tumours and Multiple Myeloma: a Single-Centre, Open-Label, Phase 1 Dose-Escalation and Basket Dose-Expansion Study